Aristolochia chlamydophylla

Aristolochia chlamydophylla

Aristolochia chlamydophylla is a plant native to certain regions, though its traditional medicinal uses are not well-documented. The available literature primarily focuses on related species such as Aristolochia debilis and Aristolochia lagesiana var. intermedia, which have been studied for their potential biological activities. Scientific evidence from studies involving these related species indicates that compounds isolated from the leaves can induce oviposition responses in butterflies and include aporphine and bisaporphine alkaloids. However, there is limited direct evidence regarding A. chlamydophylla itself. Safety concerns are not prominently reported for this plant, nor have any significant drug interactions been documented. Given the lack of specific traditional uses for A. chlamydophylla, further research would be beneficial to explore its potential applications and risks more comprehensively.

At a glance
Best evidence
D
Cautions

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.

What the science says

  • The study reports a case of grade II vesicoureteral reflux post-right-sided RNU in a patient with non-invasive UTUC, highlighting the need for vigilant monitoring. D PMID
  • The study identified compounds from Aristolochia debilis leaves that induced similar oviposition responses in Atrophaneura alcinous butterflies as whole leaves. D PMID
  • The incidence of upper urinary tract transitional cell cancer is significantly higher in areas endemic to Balkan endemic nephropathy. D PMID
  • Aporphine and bisaporphine alkaloids were isolated from the leaves of Aristolochia lagesiana var. intermedia, including new dimeric and monomeric structures. D PMID
  • UTUC associated with AAN was more common in females, had higher tumor grades, and showed worse overall and recurrence-free survival rates. D PMID

Frequently asked questions

What is Aristolochia chlamydophylla?

Aristolochia chlamydophylla (Aristolochia chlamydophylla) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Aristolochia chlamydophylla?

5 sourced findings are recorded for Aristolochia chlamydophylla; the strongest carries evidence grade D. For example: The study reports a case of grade II vesicoureteral reflux post-right-sided RNU in a patient with non-invasive UTUC, highlighting the need for vigilant monitoring.

How strong is the evidence for Aristolochia chlamydophylla?

The strongest finding for Aristolochia chlamydophylla carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Aristolochia chlamydophylla safe? What are the side effects?

No major safety issues are recorded for Aristolochia chlamydophylla in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Aristolochia chlamydophylla interact with medications?

No drug interactions are recorded for Aristolochia chlamydophylla in our sources. This does not rule them out — check with a pharmacist.

Is Aristolochia chlamydophylla a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Sources

  1. T2 Aporphine and bisaporphine alkaloids from Aristolochia lagesiana var. intermedia. literature abstract metadata
  2. T2 Oviposition stimulants of an Aristolochiaceae-feeding swallowtail butterfly,Atrophaneura alcinous. literature abstract metadata
  3. T2 What do we know about the Balkan endemic nephropathy and the uroepithelial tumors? literature abstract metadata
  4. T2 Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy. literature abstract metadata
  5. T2 Vesicoureteral reflux postoperative radical nephroureterectomy for upper urinary tract urothelial carcinoma: A case report. literature abstract metadata